戻る Agenda
Session 1 Track 1: Improving Clinical Trials Using Digital Tools: Opportunities Ready for Prime Time
Session Chair(s)
Jennifer Goldsack, MA, MBA, MS
Chief Executive Officer
Digital Medicine Society (DiMe), United States
Digital tools offer the potential to improve the efficiency, probability of success, and patient centricity of clinical trials. In addition, opportunities for digital innovation exist throughout the clinical trials lifecycle. Consequently, sponsors today face a proliferation of digital products being touted as solutions. This session aims to first help identify challenges in our industry well suited to digital solutions, then support the evaluation and implementation of solutions available today.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Identify challenges in clinical trials that are particularly well suited to digital solutions
- Discuss digital tools currently deployed in clinical trials, characteristics of these tools, and the value they offer patients and sponsors
- Describe the impact of digital tools on trial design and conduct, including decentralized and hybrid clinical trials
Speaker(s)
Speaker
Bray Patrick-Lake, MS
FDA, United States
Senior Digital Health Specialist, DDH, CDRH
Speaker
Daniel Rollings Karlin, DrMed, MA, FAPA
MindMed, United States
Chief Medical Officer
Decentralized Clinical Trials (DCTs) Using Digital Health Technologies (DHTs)
Isaac R Rodriguez-Chavez, MHS, PhD, MS
Independant Consultancy, United States
Independant Consultant